Literature DB >> 4278249

Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin.

J P Fillastre, J Maitrot, M A Canonne, H Gray, C Jeanne, P Bastit, T Bourgeois.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4278249     DOI： 10.1159/000221817

Source DB:  PubMed          Journal:  Chemotherapy        ISSN： 0009-3157            Impact factor:   2.544


× No keyword cloud information.
  4 in total

Review 1.  Comparative tolerability of drug therapies for hypercalcaemia of malignancy.

Authors:  N Zojer; A V Keck; M Pecherstorfer
Journal:  Drug Saf       Date:  1999-11       Impact factor: 5.606

2.  Calcium free hemodialysis: an effective therapy in hypercalcemic crisis--report of 4 cases.

Authors:  W Kaiser; G Biesenbach; R Kramar; J Zazgornik
Journal:  Intensive Care Med       Date:  1989       Impact factor: 17.440

3.  Furosemide, mithramycin, and salmon calcitonin in hypercalcemia.

Authors:  J P Filastre; G Humbert; J Leroy; J Maitrot; P Deshayes; M A Canonne
Journal:  Eur J Intensive Care Med       Date:  1975-12

4.  Cardiac arrest associated with hypokalaemia in a patient receiving mithramycin.

Authors:  Y Bashir; C R Tomson
Journal:  Postgrad Med J       Date:  1988-03       Impact factor: 2.401
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.